Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal single-ascending-dose Xen2174 PK/PD study in healthy volunteers
NL-OMON35658Active, not recruiting
- Sponsor
- Xenome Ltd
- Start
- Dec 2011
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of Xen2174 in postoperative pain and pain (6 arms), sponsored by Xenome Ltd. Primary endpoints: Pressure pain threshold and tolerance, Electrical pain threshold and tolerance - single stimulus and 7 more. Started Dec 2011; status: active, not recruiting.
02
Drugs
Xen2174
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on NL-OMON35658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35658.